BioReperia Alternatives & Competitors
12 companies similar to BioReperia — Accelerating drug discovery and predicting the best cancer treatment for you!
Companies similar to BioReperia
XenTech
Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 y...
Evry, France
Oniria Therapeutics
A shift in cancer treatment methodology makes a world of difference.
Barcelona, Spain
Gordion Bioscience
MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING
Boston, United States
Soricimed Biopharma Inc.
Dedicated to developing effective and novel targeted treatments for cancer.
Canada
Rival Readout
Competing with BioReperia? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Viracta Therapeutics, Inc.
A precision oncology company focused on the treatment and prevention of virus-associated c...
United States
VRise Therapeutics, Inc.
A Precision Oncology Company
Cambridge, United States
Umoja Biopharma
Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer b...
Helioson
A biopharmaceutical pioneer dedicated to creating groundbreaking therapies for cancer.
Sensei Bio
We follow the immune system’s teachings to discover new treatments that inspire the body t...
Rockville, United States
Flexus Biosciences
Bristol-Myers Squibb acquired Flexus for $800M upfront & $450M in potential earnouts in 20...
Day One Biopharmaceuticals
Cancer drug development comes of age.
Brisbane, United States
About BioReperia
BioReperia is a Swedish startup that is revolutionizing the fields of drug discovery and cancer treatment with its unique ZTX® platform (zebrafish tumor xenograft). The company's slogan, "Accelerating drug discovery and predicting the best cancer treatment for you!", encapsulates its mission to personalize and expedite...
Drug Discovery, Precision Medicine, Cancer Treatment, Zebrafish Models, Contract Research Organization, In Vivo Model, Tumor Xenograft, Metastasis Inhibition, Immuno-therapies, Patient-derived Xenografts, Swedish Biotech, Oncology Research, Bioinformatics, Biomedical Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around BioReperia: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at BioReperia on 12 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
